Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/4937| Title: | Semaglutide in obesity and type 2 diabetes : A review of clinical trial evidence from 1 to 5 semaglutide treatment effect in people with obesity program |
| Authors: | Aastha Khanna |
| Keywords: | Glucsgon-like peptide-1 antagonist obesity semaglutide semaglutide treatment effect in pepole with boesity trials type 2 diabetes |
| Issue Date: | 29-May-2026 |
| Description: | Vol 58, No. 3, p 166 |
| URI: | http://111.93.178.142:25000/jspui/handle/123456789/4937 |
| Appears in Collections: | Vol 58, No. 3, 2026 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 1.pdf | Vol 58, No. 3, p 166 | 150.53 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.